SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-22-003700
Filing Date
2022-01-26
Accepted
2022-01-26 13:52:20
Documents
2
Group Members
REGALS CAPITAL MANAGEMENT LPREGALS FUND LP

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea154519-13gslager_pluristem.htm SC 13G 83524
2 AGREEMENT OF JOINT FILING ea154519ex99-1_pluristem.htm EX-99.1 4093
  Complete submission text file 0001213900-22-003700.txt   89210
Mailing Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409
Business Address MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 972-74-710-7171
PLURISTEM THERAPEUTICS INC (Subject) CIK: 0001158780 (see all company filings)

IRS No.: 980351734 | State of Incorp.: NV | Fiscal Year End: 0630
Type: SC 13G | Act: 34 | File No.: 005-78785 | Film No.: 22557183
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 152 WEST 57TH STREET, 9TH FLOOR NEW YORK NY 10019
Business Address
Slager David Mark (Filed by) CIK: 0001477733 (see all company filings)

Type: SC 13G